Reactive oxygen species have been implicated in the pathogenesis of contrast-induced nephropathy (CIN). We investigated the relationship between CIN with paraoxonase 1 (PON-1) activity and oxidative stress markers (total antioxidant status [TAS], total oxidant status [TOS], and oxidative stress index [OSI]) in patients with anterior ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention; 289 consecutive patients with STEMI were prospectively included. The patients were divided into 2 groups: CIN (n = 69) and non-CIN (n = 220). Activity of PON-1 and TAS levels were significantly lower and OSI and TOS levels were significantly higher in patients with CIN compared to the non-CIN group (P < .05, for all). On multivariate logistic regression analysis, PON-1 activity and OSI as well as the amount of contrast medium and diabetes were independent predictors for CIN in patients with anterior STEMI. Activity of PON-1 and oxidative stress may play a role in the pathogenesis of CIN.
ElbasanZŞahinDYGürM. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology. 2014;65(1):37–42.
2.
RihalCSTextorSCGrillDE. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259–2264.
3.
SadeghiHMStoneGWGrinesCL. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108(22):2769–2775.
4.
MarenziGLauriGAssanelliE. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44(9):1780–1785.
5.
McCulloughPA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51(15):1419–1428.
6.
HeymanSNRosenSKhamaisiMIdéeJMRosenbergerC. Reactive oxygen species and the pathogenesis of radiocontrast- induced nephropathy. Invest Radiol. 2010;45(4):188–195.
7.
ErelO. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37(4):277–285.
8.
ErelO. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–1111.
9.
AviramMRosenblatMBisgaierCL. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest. 1998;101(8):1581–1590.
10.
AkçayABCamsarıAOzcanT. The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome. Turk Kardiyol Dern Ars. 2011;39(5):371–377.
11.
KillipTKimballJT. Treatment of myocardial infarction in a coronary care unit: a two year experience of 250 patients. Am J Cardiol. 1967;20(4):457–464.
12.
SchillerNBShahPMCrawfordM. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echocardiogr. 1989;2(5):358–367.
13.
ThomsenHSMorcosSK. Contrast media and the kidney: European society of urogenital radiology (ESUR) guidelines. Br J Radiol. 2003;76(908):513–518.
14.
JuretićDTadijanovićMRekićBSimeon-RudolfVReinerEBaricićM. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Croat Med J. 2001;42(2):146–150.
15.
EckersonHWWyteCMLa DuBN. The human serum paraoxonase/arylesterase polymorphism. AmJ Hum Genet. 1983;35:1126–1138.
BeckerLB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res. 2004;61(3):461–470.
24.
UedaJNygrenAHansellPUlfendahlHR. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiologica. 1993;34(1):83–87.
SandhuCNewmanDJMorganRBelliAMOliveiraD. The role of oxygen free radicals in contrast induced nephrotoxicity. Acad Radiol. 2002;9(suppl 2):S436–S437.
27.
FiaccadoriEMaggioreURotelliC. Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with nonionic radiocontrast media. Nephrol Dial Transplant. 2004;19(4):865–869.
28.
DuongMHMacKenzieTAMalenkaDJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv. 2005;64(4):471–479.
29.
NallamothuBKShojaniaKGSaintS. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med. 2004;117(12):938–947.
30.
SpargiasKAlexopoulosEKyrzopoulosS. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004;110(18):2837–2842.
31.
SadatUUsmanAGillardJHBoyleJR. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials. J Am Coll Cardiol. 2013;62(23):2167–2175.
32.
TasanarongAVohakiatAHutayanonPPiyayotaiD. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. Nephrol Dial Transplant. 2013;28(2):337–344.
33.
FarmerJA: Pleiotropic effects of statins. Curr Atheroscler Rep. 2000;2(3):208–217.
34.
MikhailidisDPAthyrosVG. Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI. Nat Rev Nephrol. 2014;10(1):8–9.
35.
ShahPK. Apolipoprotein A-I/HDL infusion therapy for plaque stabilization-regression: a novel therapeutic approach. Curr Pharm Des. 2007;13(10):1031–1038.
